Link between heart disease, cholesterol, and Alzheimer's disease: a review |
| |
Authors: | Sparks D L Martin T A Gross D R Hunsaker J C |
| |
Affiliation: | Haldeman Laboratory for Alzheimer's Disease Research, Sun Health Research Institute, Sun City, Arizona, USA. Lsparks@mail.sunhealth.org |
| |
Abstract: | Increased prevalence of Alzheimer's disease-like beta-amyloid deposits in the neuropil and within neurons occurs in the brains of non-demented individuals with heart disease. Heart disease is a prevalent finding in Alzheimer's disease, and may be a forerunner to the dementing disorder. In the cholesterol-fed rabbit model of human coronary heart disease there is production and accumulation of beta-amyloid in the brain. This accumulation of beta-amyloid can be reversed by removing cholesterol from the rabbits' diet. In culture cells, a cholesterol challenge has been shown to increase production of beta-amyloid, and dramatic reductions of cholesterol produced by HMG Co-A reductase inhibitors decrease production of beta-amyloid. Increased beta-amyloid production is also produced by dietary cholesterol in a number of transgenic mouse models of Alzheimer's disease. Administration of HMG Co-A reductase inhibitors may block beta-amyloid production caused by dietary cholesterol in rabbits. Clinical trials testing the benefit of HMG Co-A reductase inhibitors in the treatment of Alzheimer's disease are underway. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|